These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35964317)

  • 1. [Effective Viral Delivery of Genetic Constructs to Neuronal Culture for Modeling and Gene Therapy of GNAO1 Encephalopathy].
    Lunev EA; Shmidt AA; Vassilieva SG; Savchenko IM; Loginov VA; Marina VI; Egorova TV; Bardina MV
    Mol Biol (Mosk); 2022; 56(4):604-618. PubMed ID: 35964317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation.
    Silachev D; Koval A; Savitsky M; Padmasola G; Quairiaux C; Thorel F; Katanaev VL
    Acta Neuropathol Commun; 2022 Jan; 10(1):9. PubMed ID: 35090564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Interference Effectors Selectively Silence the Pathogenic Variant
    Klementieva NV; Lunev EA; Shmidt AA; Loseva EM; Savchenko IM; Svetlova EA; Galkin II; Polikarpova AV; Usachev EV; Vassilieva SG; Marina VI; Dzhenkova MA; Romanova AD; Agutin AV; Timakova AA; Reshetov DA; Egorova TV; Bardina MV
    Nucleic Acid Ther; 2024 Apr; 34(2):90-99. PubMed ID: 38215303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic modeling of GNAO1 disorder delineates mechanisms of Gαo dysfunction.
    Wang D; Dao M; Muntean BS; Giles AC; Martemyanov KA; Grill B
    Hum Mol Genet; 2022 Feb; 31(4):510-522. PubMed ID: 34508586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Cases and the Molecular Profiling of a Novel Childhood Encephalopathy-Causing
    Larasati YA; Solis GP; Koval A; Griffiths ST; Berentsen R; Aukrust I; Lesca G; Chatron N; Ville D; Korff CM; Katanaev VL
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV9-Mediated Intrastriatal Delivery of
    Roy AJ; Leipprandt JR; Patterson JR; Stoll AC; Kemp CJ; Oula ZD; Mola T; Batista AR; Sortwell CE; Sena-Esteves M; Neubig RR
    J Pharmacol Exp Ther; 2024 Jul; 390(2):250-259. PubMed ID: 38866563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-function mutation in Gnao1: a murine model of epileptiform encephalopathy (EIEE17)?
    Kehrl JM; Sahaya K; Dalton HM; Charbeneau RA; Kohut KT; Gilbert K; Pelz MC; Parent J; Neubig RR
    Mamm Genome; 2014 Jun; 25(5-6):202-10. PubMed ID: 24700286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Movement disorder in
    Feng H; Sjögren B; Karaj B; Shaw V; Gezer A; Neubig RR
    Neurology; 2017 Aug; 89(8):762-770. PubMed ID: 28747448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes.
    Feng H; Larrivee CL; Demireva EY; Xie H; Leipprandt JR; Neubig RR
    PLoS One; 2019; 14(1):e0211066. PubMed ID: 30682176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of GNAO1-Related Disorder Correlates with Changes in G-Protein Function.
    Domínguez-Carral J; Ludlam WG; Junyent Segarra M; Fornaguera Marti M; Balsells S; Muchart J; Čokolić Petrović D; Espinoza I; Ortigoza-Escobar JD; Martemyanov KA;
    Ann Neurol; 2023 Nov; 94(5):987-1004. PubMed ID: 37548038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.
    Kelly M; Park M; Mihalek I; Rochtus A; Gramm M; Pérez-Palma E; Axeen ET; Hung CY; Olson H; Swanson L; Anselm I; Briere LC; High FA; Sweetser DA; ; Kayani S; Snyder M; Calvert S; Scheffer IE; Yang E; Waugh JL; Lal D; Bodamer O; Poduri A
    Epilepsia; 2019 Mar; 60(3):406-418. PubMed ID: 30682224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: Cautions in interpretation of genomic test results.
    Gerald B; Ramsey K; Belnap N; Szelinger S; Siniard AL; Balak C; Russell M; Richholt R; De Both M; Claasen AM; Schrauwen I; Huentelman MJ; Craig DW; Rangasamy S; Narayanan V
    Semin Pediatr Neurol; 2018 Jul; 26():28-32. PubMed ID: 29961512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons.
    Akamine S; Okuzono S; Yamamoto H; Setoyama D; Sagata N; Ohgidani M; Kato TA; Ishitani T; Kato H; Masuda K; Matsushita Y; Ono H; Ishizaki Y; Sanefuji M; Saitsu H; Matsumoto N; Kang D; Kanba S; Nakabeppu Y; Sakai Y; Ohga S
    FASEB J; 2020 Dec; 34(12):16601-16621. PubMed ID: 33107105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanistic review on GNAO1-associated movement disorder.
    Feng H; Khalil S; Neubig RR; Sidiropoulos C
    Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gnao1 is a molecular switch that regulates the Rho signaling pathway in differentiating neurons.
    Taira R; Akamine S; Okuzono S; Fujii F; Hatai E; Yonemoto K; Takemoto R; Kato H; Masuda K; Kato TA; Kira R; Tsujimura K; Yamamura K; Ozaki N; Ohga S; Sakai Y
    Sci Rep; 2024 Jul; 14(1):17097. PubMed ID: 39048611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Encephalopathy GNAO1].
    Bobylova MY; Volkov IV; Gumennik EV; Rachmanina OA; Abramov MO; Volkova OK; Bayborina TS; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):122-130. PubMed ID: 36719128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual Function in Children with GNAO1-Related Encephalopathy.
    Gambardella ML; Pede E; Orazi L; Leone S; Quintiliani M; Amorelli GM; Petrianni M; Galanti M; Amore F; Musto E; Perulli M; Contaldo I; Veredice C; Mercuri EM; Battaglia DI; Ricci D
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis.
    Kim SY; Shim Y; Ko YJ; Park S; Jang SS; Lim BC; Kim KJ; Chae JH
    Orphanet J Rare Dis; 2020 Dec; 15(1):343. PubMed ID: 33298085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulatory role of Gnao1 protein in diabetic encephalopathy in KK-Ay mice and streptozotocin-induced diabetic rats.
    Xu S; Yu W; Zhang X; Wang W; Wang X
    Brain Res; 2022 Oct; 1792():148012. PubMed ID: 35839930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Dynamic Simulations to Determine Individualized Therapy: Tetrabenazine for the GNAO1 Encephalopathy E246K Variant.
    Falsaperla R; Sortino V; Marino SD; Collotta AD; Gammeri C; Sipala FM; Volti GL; Ruggieri M; Ronsisvalle S
    Mol Diagn Ther; 2024 May; 28(3):329-337. PubMed ID: 38581611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.